Financial rounds

We have close ties with venture and private equity funds and investment banking active in the Life Sciences arena. As we are used to performing due diligence reviews for the same entities, we are also in a position to advise emerging biotech companies to employ a systemized approach to introduce their business to investors interested in the company’s technology, the stage of development, the goals for growth and the legal strategy for ensuring due protection.